Trials / Completed
CompletedNCT02105272
Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 237 (actual)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the efficacy and safety of OPC-1085EL ophthalmic solution in comparison with latanoprost ophthalmic solution in subjects who are insufficiently responsive to latanoprost ophthalmic solution.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OPC-1085EL ophthalmic solution | |
| DRUG | Latanoprost ophthalmic solution |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2014-04-07
- Last updated
- 2015-12-21
- Results posted
- 2015-11-17
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02105272. Inclusion in this directory is not an endorsement.